These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33300698)

  • 1. [Contraception and venous thromboembolism].
    Blondon M; Casini A; Fontana P; Hugon-Rodin J
    Rev Med Suisse; 2020 Dec; 16(718):2383-2386. PubMed ID: 33300698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal contraception and thrombosis.
    Sitruk-Ware R
    Fertil Steril; 2016 Nov; 106(6):1289-1294. PubMed ID: 27678035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal management of hormonal contraceptives after an episode of venous thromboembolism.
    Klok FA; Barco S
    Thromb Res; 2019 Sep; 181 Suppl 1():S1-S5. PubMed ID: 31477219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
    Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
    Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraception-related venous thromboembolism in adolescents.
    O'Brien SH
    Semin Thromb Hemost; 2014 Feb; 40(1):66-71. PubMed ID: 24356931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
    Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
    Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis.
    Douxfils J; Raskin L; Didembourg M; Donis N; Dogné JM; Morimont L; Beaudart C
    Front Endocrinol (Lausanne); 2024; 15():1428597. PubMed ID: 39220361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestin-only contraception and venous thromboembolism.
    Blanco-Molina MA; Lozano M; Cano A; Cristobal I; Pallardo LP; Lete I
    Thromb Res; 2012 May; 129(5):e257-62. PubMed ID: 22425318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in women taking hormonal contraceptives.
    Blanco-Molina A; Monreal M
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O; Spinar J; Musil V; Pozdísek Z
    Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in women: a specific reproductive health risk.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2013; 19(5):471-82. PubMed ID: 23825156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
    Plu-Bureau G; Horellou MH; Gompel A; Conard J
    Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
    Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
    Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal contraception and venous thromboembolism.
    Lidegaard Ø; Milsom I; Geirsson RT; Skjeldestad FE
    Acta Obstet Gynecol Scand; 2012 Jul; 91(7):769-78. PubMed ID: 22568831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the use of hormonal contraception in Estonia 2005-2019 and the risk of arterial and venous thromboembolism: a population-based study.
    Kurvits K; Laius O; Uusküla M; Laanpere M
    Eur J Contracept Reprod Health Care; 2021 Oct; 26(5):413-420. PubMed ID: 34160334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.